SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Hypertension Diagnostics Inc (HDII)
HDII 0.00010000.0%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scott_jiminez who wrote (110)9/25/2002 3:25:47 PM
From: scott_jiminez  Read Replies (1) of 120
 
The remarkable plunge in short sales continues...

The new (September) data is in: short interest for HDII = 15,940

That's a decline of 62% from August (and a decline of 94% - from 257,259 - in the past 4 months).

The ratio of short interest to average daily volume - probably the most accurate gauge of real shorting activity - is now 0.38. This is a remarkable number as well since it was at 6.83 in May of this year and was at 26.45 one year ago.

In light of some of the recent news regarding hypertension (see siliconinvestor.com, this long term trend which has transformed a huge short position in HDII to one that has essentially vanished strongly suggests there's now a good deal of optimism the company will be fully involved in screening this very large, and rapidly expanding, population.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext